ASHWINII HERBAL HONEY
ASHWINII HERBAL HONEY : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Myristica fragrans Houtt.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Elettaria cardamomum | Elettaria cardamomum[10.0MG/5ML] | Not identified |
| Myristica fragrans | Myristica fragrans[10.0MG/5ML ] | Not identified |
| Piper nigrum | Piper nigrum[10.0MG/5ML ] | Not identified |
| Rosa damascena | Rosa damascena[10.0MG/5ML ] | Not identified |
| Trifolium pratense | Trifolium pratense[10.0MG/5ML] | Not identified |
| Vitis Vinifera | Vitis Vinifera[600.0MG/5ML ] | Not identified |
| Zingiber zerumbet | Zingiber zerumbet[10.0MG/5ML] | Not identified |
| HONEY | HONEY[1.0ML/5ML] | Miel |
| ZIZANIA AQUATICA | ZIZANIA AQUATICA[10.0MG/5ML] | Not identified |
| ZINGIBER OFFICINALE EXTRAXT | ZINGIBER OFFICINALE EXTRAXT[0.25GM/5ML ] | Not identified |
| Glycyrrhiza glabra | Glycyrrhiza glabra[10.0MG/5ML ] | Not identified |
| FRUCTUS PIPER LONGUM | FRUCTUS PIPER LONGUM[10.0MG/5ML ] | Not identified |
| CITRUS AURANTIFOLIA (LIME OIL) | CITRUS AURANTIFOLIA (LIME OIL)[10.0MG/5ML ] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL19971140TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- ZONTRON PHARMACEUTICALS SDN. BHD.
- Manufacturer
- TERAPUTICS SDN BHD
- Registration period starting
- 2023-08-03
- Published validity end
- 2028-08-03
Original register data
View published fields and their variants
- Active ingredients
- Elettaria cardamomum[10.0MG/5ML],Myristica fragrans[10.0MG/5ML ],Piper nigrum[10.0MG/5ML ],Rosa damascena[10.0MG/5ML ],Trifolium pratense[10.0MG/5ML],Vitis Vinifera[600.0MG/5ML ],Zingiber zerumbet[10.0MG/5ML],HONEY[1.0ML/5ML],ZIZANIA AQUATICA[10.0MG/5ML],ZINGIBER OFFICINALE EXTRAXT[0.25GM/5ML ],Glycyrrhiza glabra[10.0MG/5ML ],FRUCTUS PIPER LONGUM[10.0MG/5ML ],CITRUS AURANTIFOLIA (LIME OIL)[10.0MG/5ML ]
- Valid until
- 2028-08-03
- Registration date
- 2023-08-03
- Published description
- NATURAL PRODUCT
- Licence holder
- ZONTRON PHARMACEUTICALS SDN. BHD.
- Producer
- TERAPUTICS SDN BHD
- Published name
- ASHWINII HERBAL HONEY
- Published reference
- 1995086405T
- Registration number
- MAL19971140TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL19971140TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycyrrhiza glabra
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
Sources cited by Health Canada (1)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
Sources cited by Health Canada (2)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ASHWINII HERBAL HONEY”, https://compoatlas.com/en/supplements/malaysia/MAL19971140TC-ashwinii-herbal-honey, updated 27 October 2026.